Clusterin in bovine spongiform encephalopathy (BSE)

Journal of Comparative Pathology

Volumn 121, Issue 2, 1999, Pages 159-171

  McHattie, S ^a   Wells, G A H ^b   Bee, J ^a   Edington, N ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; MESSENGER RNA; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CERVICAL SPINAL CORD; CONTROLLED STUDY; GLIA; GRAY MATTER; NERVE FIBER DEGENERATION; NEUROPIL; NONHUMAN; PROTEIN EXPRESSION; SPINAL CORD DORSAL HORN; THALAMUS; WHITE MATTER;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE SPONGIFORM ENCEPHALOPATHY PRION;

EID: 0033178972     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcpa.1999.0313     Document Type: Article

References (28)

1. Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H. and Bostock, C. J. (1997). Transmission to mice indicates that new variant CJD is caused by the BSE agent. Nature, 389, 498-501.
2. Choi-Miura, N. H. and Oda, T. (1996). Relationship between multifunctional protein "clusterin" and Alzheimer's disease. Neurobiology - Aging, 17, 717-722.
3. Chomczynski, P. and Sacchi, N. (1987). Single step method of RNA extraction by acid guanidium thiocyanate-phenol-chloroform. Analytical Biochemistry, 162, 156-159.
4. Collinge, J., Kidle, K. C. L., Meads, J. Ironside, J. and Hill, A. F. (1996). Molecular analysis of prion strain variation and the aetiology of new variant CJD. Nature, 383, 685-690.
5. Day, J. R., Laping, N. J., McNeill, T. H., Schreiber, S. S., Pasinetti, G and Finch, C. E. (1990). Castration enhances expression of GFAP and SGP 2 in the intact and lesion-altered hippocampus of the adult rat. Molecular Endocrinology, 4, 1995-2002.
6. Duguid, J. R., Bochmont, C. W., Liu, N. and Tourtelotte, W. W. (1989). Localisation of SGP 2/ clusterin mRNA in the mouse brain by in situ hybridisation. Proceedings of the National Academy of Sciences of the USA, 86, 7260-7264.
7. Garden, G. A., Bothwell, M. and Rubel, E. M. (1991). Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. Journal of Neurobiology, 22, 590-604.
8. Hammad, S. M., Ranganathan, S., Loukinova, E., Twal, W. O. and Argaves, W. S. (1997). Interaction of apolipoprotein J amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. Journal of Biological Chemistry, 272, 18644-18649.
9. Hill, A. F., Butterworth, R. J., Joiner, S., Jackson, G., Rossor, M. N., Thomas, D. J., Frosh, A., Tolley, N., Bell, J. E., Spencer, M., King, A., Al-Sarraj, S., Ironside, J. W., Lantos, P. L. and Collinge, J. (1999). Investigation of variant Creutzfeldt-Jacob disease and other prion diseases with tonsil biopsy samples. Lancet, 353, 183-189.
10. Hope, J., Reekie, L. J. D., Hunter, N., Multhaup, G., Beyreuther, K., White, H., Scott, A. C., Stack, M. J., Dawson, M. and Wells, G. A. H. (1988). Brain fibrils of novel British cattle disease contain scrapie-associated protein. Nature, 336, 390-392.
11. Kitamoto, T., Ogomori, K., Tateishi, J. and Prusiner, S. B. (1987). Formic acid treatment enhances immunostaining of cerebral and systemic amyloids. Laboratory Investigation, 57, 230-236.
12. Kounnas, M. Z., Loukinova, E. B., Stefansson, S., Harmony, J. A. K., Brewer, B. H., Strickland, D. H. and Argraves, W. S. (1995). Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. Journal of Biological Chemistry, 270, 13070-13075.
13. Laping, N. J., Morgan, T. E., Nichols, N. R., Rozovsky, C. S., Young-Chan, C. S., Zarow, C. and Finch, C. E. (1994). Transforming growth factor-β1 induces neuronal and astrocytic genes: tubulin α1, glial fibrillary acidic protein and clusterin. Neuroscience, 58, 563-572.
14. Laslop, A., Steiner, H. J., Egger, C., Wolkersdorfer, M., Kapelari, S., Hogue-Angeletti, R., Erickson, J. D., Fischer-Colbrie, R. and Winkler, H. (1993). Glycoprotein III (clusterin, sulphated glycoprotein 2) in endocrine, nervous and other tissues: immunocytochemical characterization, subcellular localization and regulation of biosynthesis. Journal of Neurocytochemistry, 61, 1498-1505.
15. Maniatis, T., Fritsch, E. F. and Sambrook, J. (1982). Molecular Cloning, a Laboratory Manual, Cold Spring Harbor, New York, pp. 202-203.
16. May, P. C. and Finch, C. E. (1992). Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends in Neuroscience, 15, 391-395.
17. May, P. C., Lampert-Etchells, M. A., Johnson, S. A., Poirer, J., Masters, J. N. and Finch, C. E. (1990). Dynamics of gene expression for a hippocampal protein elevated in AD and in experimental lesions in rats. Neuron, 5, 831-839.
18. McHattie, S. (1999). The role of clusterin in bovine spongiform encephalopathy. PhD Thesis, University of London.
19. BSE in BSE spinal cord, and inhibits fibrillogenesis of the amyloidogenic peptide PrP 106-126 in vitro. Brain Research Association Abstracts, 14, 47.
20. Nudel, U., Zakut, R., Shani, M., Neuman, S., Levy, Z. and Yaffe, D. (1983). Nucleotide sequence of the rat β-actin gene. Nucleic Acids Research, 11, 1759-1771.
21. O'Bryan, M. K., Cheema, S. S., Bartlett, P. F., Murphy, B. F. and Pearse, M. J. (1993). Clusterin levels increase during neuronal development. Journal of Neurobiology, 24, 421-432.
22. Palmer, D. J. and Christie, D. L. (1990). The primary structure of glycoprotein III from bovine adrenal medullary chromaffin granules. Journal of Biological Chemistry, 265, 6617-6623.
23. Pasinetti, G. M., Johnson, S. A., Oda, T., Rozovsky, S. K. and Finch, C. E. (1994). Clusterin (SGP-2): a multi-functional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. Journal of Comparative Neurology, 339, 387-400.
24. Prusiner, S. B. (1993). Genetic and infectious prion diseases. Archives of Neurology, 50, 1123-1129.
25. Rosenberg, M. E. and Silkensen, J. (1995). Clusterin: physiological and pathophysiological considerations. International Biochemistry and Cell Biology, 27, 633-645.
26. Wells, G. A. (1993). Pathology of nonhuman spongiform encephalopathies: variations and their implications for pathogenesis. Developing Biological Standards, 80, 61-69.
27. Wells, G. A. H., Scott, A. C., Johnson, C. T., Gunning, R. F., Hancock, R. D., Jeffrey, M., Dawson, M. and Bradley, R. (1987). A novel progressive spongiform encephalopathy in cattle. Veterinary Record, 121, 419-420.
28. Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb J. G., Zheng, G., McCluskey, R. T., Frangione, B. and Ghiso, J. (1996). Glycoprotein 330/megalin: probable role in receptor mediated transport of Apo J alone and in complex with AD amyloid B at the blood brain and blood cerebrospinal fluid barriers. Proceedings of the National Academy of Sciences of the USA, 93, 4229-4234.